FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to carbon monoxide antidote, which is 1-butyl-5-oxyiminopergidropyrimidin-2,4,6-trionata zinc acetate with structural formula: .
EFFECT: invention can be used for treating and preventing of carbon monoxide (CO) poisoning, as well as for treatment of hypoxic states of various aetiology.
1 cl, 9 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIDOTE FOR CARBON MONOXIDE AND HEPATOTOXIC SUBSTANCES | 2015 |
|
RU2584586C1 |
METHOD FOR REDUCING THE SEVERITY OF THE LONG-TERM EFFECTS OF CARBON MONOXIDE POISONING | 2019 |
|
RU2723165C1 |
METHOD OF PREVENTING CHRONIC TOXIC ARTERIAL HYPERTENSION AND CARDIOPATHY IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2363454C1 |
ENCAPSULATED FORM OF ACYZOL | 2005 |
|
RU2290928C1 |
METHOD OF PREVENTING TOXIC LEAD EFFECT ON EXPERIMENT ANIMALS WITH CHRONIC POISONING | 2008 |
|
RU2358328C1 |
MIXED COBALT (II) SALTS OF KETOCARBOXYLIC AND MERCAPTOCARBOXYLIC ACIDS AND HYDRATES THEREOF, OR SOLVATES THEREOF, METHODS FOR PRODUCTION AND USE THEREOF AS CYANIDE ANTIDOTES | 2013 |
|
RU2553275C2 |
ANTIDOTE OF CARBON MONOXIDE AND METHOD OF ITS APPLICATION | 2010 |
|
RU2425676C1 |
METHOD FOR PREVENTING EXPERIMENTAL TOXIC NEPHROPATHY | 2019 |
|
RU2716509C1 |
SOLUTION FOR MAKING INJECTIONS | 2004 |
|
RU2276978C2 |
METHOD OF CADMIUM NEPHROPATHY PREVENTION IN EXPERIMENTAL ANIMALS SUFFERING FROM CHRONIC POISONING | 2008 |
|
RU2366459C1 |
Authors
Dates
2016-04-20—Published
2015-04-06—Filed